Intercept 302 EU Study


Intercept 302 EU Study
Download on the AppStore Click here to request a review of this app

  • App Store Info

Description

This telemedicine app is intended to be used by patients enrolled in Intercept's 302 EU study. The purpose of this app is to connect patients and clinician's for the purpose of Intercept's study. Patients will use this app to schedule and conduct telemedicine calls.

This app is intended for users who are age 18 and over.

What's New in Version 3.0

Telemedicine 3 party call feature added

Screenshots

Screenshot 1 of 5 Screenshot 2 of 5 Screenshot 3 of 5 Screenshot 4 of 5 Screenshot 5 of 5